Iridex Announces First Quarter 2022 Financial Results
May 12, 2022 16:05 ET
|
IRIDEX Corporation
MOUNTAIN VIEW, Calif., May 12, 2022 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX) today reported financial results for the first quarter ended April 2, 2022. First Quarter 2022 Highlights...
Iridex to Report First Quarter 2022 Financial Results on May 12, 2022
April 28, 2022 16:05 ET
|
IRIDEX Corporation
MOUNTAIN VIEW, Calif., April 28, 2022 (GLOBE NEWSWIRE) -- Iridex Corporation (NASDAQ: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and...
Iridex Announces the Appointment of Beverly Huss to its Board of Directors
March 21, 2022 16:05 ET
|
IRIDEX Corporation
MOUNTAIN VIEW, Calif., March 21, 2022 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and...
Iridex Announces Fourth Quarter and Full Year 2021 Financial Results
March 10, 2022 16:05 ET
|
IRIDEX Corporation
MOUNTAIN VIEW, Calif., March 10, 2022 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX) today reported financial results for the fourth quarter and year ended January 1, 2022. Fourth...
Iridex to Present at the 34th Annual Roth Conference
March 08, 2022 17:02 ET
|
IRIDEX Corporation
MOUNTAIN VIEW, Calif., March 08, 2022 (GLOBE NEWSWIRE) -- Iridex Corporation (NASDAQ: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and...
Iridex to Report Fourth Quarter and Full Year 2021 Financial Results on March 10, 2022
February 24, 2022 16:05 ET
|
IRIDEX Corporation
MOUNTAIN VIEW, Calif., Feb. 24, 2022 (GLOBE NEWSWIRE) -- Iridex Corporation (NASDAQ: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal...
Iridex Announces Preliminary Operational and Financial Results for Fourth Quarter and Full Year 2021
January 11, 2022 16:05 ET
|
IRIDEX Corporation
MOUNTAIN VIEW, Calif., Jan. 11, 2022 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX) today provided preliminary unaudited operational and financial results for the fourth quarter and full year...
Iridex to Present at the 2021 Stifel Virtual Healthcare Conference
November 12, 2021 08:00 ET
|
IRIDEX Corporation
MOUNTAIN VIEW, Calif., Nov. 12, 2021 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal...
Iridex Announces Third Quarter 2021 Financial Results
November 11, 2021 16:05 ET
|
IRIDEX Corporation
MOUNTAIN VIEW, Calif., Nov. 11, 2021 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX) today reported financial results for the third quarter ended October 2, 2021. Third Quarter Highlights ...
Retina and Glaucoma Experts Will Present Best Practices Using Iridex Technologies at a Consensus Panel and the AAO Annual Meeting
November 06, 2021 12:44 ET
|
IRIDEX Corporation
An international expert consensus panel will discuss best practices in dosing and patient selection using MicroPulse TLT on November 6, 2021 Panel members scheduled for discussions at the Iridex...